Assignee
MAGNANI JOHN L
US·8 granted patents·4 pending applications·223 citations·filing 1994–2021
Top patents by PatentIndex Score
12 records- 0196USRE44778EHeterobifunctional pan-selectin inhibitorsMAGNANI JOHN L·Filed 2012·Granted Feb 25, 2014·30 cites·17 claims
- 0295US8410066B2Heterobifunctional inhibitors of E-selectins and CXCR4 chemokine receptorsMAGNANI JOHN L·Filed 2010·Granted Apr 2, 2013·31 cites·33 claims
- 0393US8633303B2Heterobifunctional pan-selectin inhibitorsMAGNANI JOHN L·Filed 2011·Granted Jan 21, 2014·21 cites·19 claims
- 0493US8530448B2Compounds and methods for inhibiting selectin-mediated functionMAGNANI JOHN L·Filed 2010·Granted Sep 10, 2013·21 cites·13 claims
- 0592US8258290B2Glycomimetic inhibitors of the PA-IL lectin, PA-IIL lectin or both the lectins from pseudomonasMAGNANI JOHN L·Filed 2009·Granted Sep 4, 2012·23 cites·6 claims
- 0691US8895510B2Pan-selectin inhibitor with enhanced pharmacokinetic activityMAGNANI JOHN L·Filed 2009·Granted Nov 25, 2014·18 cites·13 claims
- 0791US8518896B2Treatment of cancers of the blood using selected glycomimetic compoundsMAGNANI JOHN L·Filed 2009·Granted Aug 27, 2013·20 cites·7 claims
- 0887US6121233AMethods for the inhibition of cancer metastasis mediated by endothelial adhesion moleculesMAGNANI JOHN L·Filed 1994·Granted Sep 19, 2000·59 cites·4 claims
- 0958US2012329755A1Glycomimetic inhibitors of the pa-il lectin, pa-iil lectin or both the lectins from pseudomonasMAGNANI JOHN L·Filed 2012·Application pending·0 cites
- 1055US2023165882A1Compounds and methods for reduction of cancer cell burden and protection of normal hematopoiesisMAGNANI JOHN L·Filed 2021·Application pending·0 cites
- 1147US2012202762A1Methods of use of glycomimetics with replacements for hexoses and n-acetyl hexosaminesMAGNANI JOHN L·Filed 2011·Application pending·0 cites
- 1240US2013261070A1Anti-epileptogenic agentsMAGNANI JOHN L·Filed 2011·Application pending·0 cites
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →